Physician profile
Gregory Perez
NPI 1558700815
$2,323.27
in general payments reported to CMS, 2019-2025
11 companies · $99.10 in 2025
The $99.10 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $1,056 · 2021: $171 · 2022: $237 · 2023: $163 · 2024: $241 · 2025: $99.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,182.15 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $406.33 | 2022-2025 | Infuse, Btod |
| Johnson & Johnson Vision Care, INC. | $180.49 | 2019-2025 | |
| Glaukos Corporation | $112.15 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $105.08 | 2024 | |
| Optos, INC. | $84.85 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $59.22 | 2021 | |
| Allergan, INC. | $58.33 | 2021 | |
| Mallinckrodt Hospital Products INC. | $56.42 | 2024 | Acthar |
| Maculogix, INC. | $39.74 | 2019 | |
| Alcon Vision LLC | $38.51 | 2019-2024 | Total30 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.